Research & Development

GP Access Rules in England Spark Nurse Workload Concerns
Research & Development GP Access Rules in England Spark Nurse Workload Concerns

The landscape of healthcare in England has undergone a notable shift with the recent updates to the general practice (GP) contract, effective from October 1, mandating that all GP surgeries maintain online consultation tools during core hours from 8 a.m. to 6:30 p.m. for routine patient inquiries.

Novel Feline Parvovirus Mutant Surges and Fades in Egypt 2023
Research & Development Novel Feline Parvovirus Mutant Surges and Fades in Egypt 2023

In a striking revelation from 2023, researchers in Egypt uncovered a previously unknown mutation of feline parvovirus (FPV), named Thr390Ala, which rapidly emerged among local cat populations, capturing the attention of veterinary scientists worldwide. This discovery, stemming from an in-depth

Healthy Habits and GLP-1 Drugs Boost Heart Health in Diabetes
Research & Development Healthy Habits and GLP-1 Drugs Boost Heart Health in Diabetes

What if a simple combination of daily choices and modern medicine could halve the risk of heart attacks for millions living with Type 2 diabetes? Across the United States, where this condition affects over 30 million people, cardiovascular disease remains the leading cause of death for those

How Do PFAS in Drinking Water Affect Blood Levels in California?
Research & Development How Do PFAS in Drinking Water Affect Blood Levels in California?

Imagine a silent contaminant lurking in the tap water of millions, undetected by taste or smell, yet capable of accumulating in the human body with potential health consequences that could impact generations. Per- and polyfluoroalkyl substances (PFAS), often called "forever chemicals" due to their

How to Navigate FDA Rules for CAR-NK Cell Therapies?
Research & Development How to Navigate FDA Rules for CAR-NK Cell Therapies?

In the rapidly advancing field of cancer treatment, chimeric antigen receptor natural killer (CAR-NK) cell therapies stand out as a groundbreaking approach, offering scalable, off-the-shelf solutions that could transform patient care. These therapies, often developed from induced pluripotent stem

Optimal Blastocyst Count for PGT-A in RPL Patients Unveiled
Research & Development Optimal Blastocyst Count for PGT-A in RPL Patients Unveiled

Recurrent pregnancy loss, often referred to as RPL and characterized by two or more consecutive miscarriages, casts a heavy shadow over the dreams of countless couples hoping to build a family. For those navigating the complex world of in vitro fertilization (IVF), a beacon of hope emerges through

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later